Global In-Vitro Diagnostics Market Forecast to 2018
Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries; however, rising economies such as India, Brazil and China are likely to witness strong growth in the coming years.
In the latest research study, “Global In-Vitro Diagnostics Market Forecast to 2018”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.
The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.
The study further delves into the business dynamics of major players in the industry that together form around 70% of the global IVD market. To provide a thorough understanding of the Company’s business model, Company’s current and historical financials have been analyzed. Also, the Company’s revenue from IVD has been depicted, with a further breakup by clinical segment. The study also portrays some of the profiled Company’s strengths and weaknesses that will help the reader to better position their company vis-à-vis competition.
In the latest research study, “Global In-Vitro Diagnostics Market Forecast to 2018”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 55.4 Billion in 2013, is expected to grow at a CAGR of around 7% during 2013-2018.
The market has been segmented keeping in mind three factors: Clinical use, Geographical scenario and Player specializations, and for every segment a current and future outlook to 2018 has been provided. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Through this research, opportunity assessment in various segments has been performed and the segments that offer the maximum opportunity for growth have been highlighted.
The study further delves into the business dynamics of major players in the industry that together form around 70% of the global IVD market. To provide a thorough understanding of the Company’s business model, Company’s current and historical financials have been analyzed. Also, the Company’s revenue from IVD has been depicted, with a further breakup by clinical segment. The study also portrays some of the profiled Company’s strengths and weaknesses that will help the reader to better position their company vis-à-vis competition.
1. ANALYST VIEW
2. RESEARCH METHODOLOGY
3. IN VITRO DIAGNOSTIC MARKET OVERVIEW
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. CLINICAL SEGMENTATION OUTLOOK 2018
4.1 Point-of-Care Diagnostics
4.2 Immunochemistry
4.3 Clinical Chemistry
4.4 Molecular Diagnostics
4.5 Hematology
4.6 Microbiology
4.7 Hemostasis
4.8 Immunohematology
5. GEOGRAPHICAL SEGMENTATION (CURRENT & FUTURE SCENARIO - 2018)
5.1 America
5.1.1 United States
5.1.2 Canada
5.1.3 Brazil
5.1.4 Mexico
5.2 Europe
5.2.1 Germany
5.2.2 France
5.2.3 Italy
5.2.4 United Kingdom
5.2.5 Spain
5.3 Asia-Pacific
5.3.1 Japan
5.3.2 China
5.3.3 India
6. INDUSTRY TRENDS
6.1 Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
6.2 On the Horizon: Non-Invasive Genetic Tests for Cancer
6.3 Non-Invasive Prenatal Diagnostics Market Witnesses Boom
6.4 Companion Diagnostics Partnerships Gear Up
6.5 Predictive Cancer Diagnostic Test Market Rockets Northwards
6.6 POCT: Expanding Avenues into Multiple Disease Diagnosis
7. COMPETITIVE LANDSCAPE
7.1 Market Share of Top Players
7.2 Key Players
7.2.1 Abbott Laboratories
7.2.2 Alere, Inc.
7.2.3 Becton Dickinson
7.2.4 Bayer HealthCare
7.2.5 Beckman Coulter
7.2.6 Biomerieux
7.2.7 Johnson and Johnson
7.2.8 Life Technologies Corporation
7.2.9 Medtronic, Inc.
7.2.10 Qiagen NV
7.2.11 Roche Holding Ltd
7.2.12 Sysmex Corporation
7.2.13 Siemens HealthCare
7.2.14 Thermo Fisher Scientific
2. RESEARCH METHODOLOGY
3. IN VITRO DIAGNOSTIC MARKET OVERVIEW
3.1 Introduction
3.2 What is In Vitro Diagnostics?
3.3 Market Size and Growth
4. CLINICAL SEGMENTATION OUTLOOK 2018
4.1 Point-of-Care Diagnostics
4.2 Immunochemistry
4.3 Clinical Chemistry
4.4 Molecular Diagnostics
4.5 Hematology
4.6 Microbiology
4.7 Hemostasis
4.8 Immunohematology
5. GEOGRAPHICAL SEGMENTATION (CURRENT & FUTURE SCENARIO - 2018)
5.1 America
5.1.1 United States
5.1.2 Canada
5.1.3 Brazil
5.1.4 Mexico
5.2 Europe
5.2.1 Germany
5.2.2 France
5.2.3 Italy
5.2.4 United Kingdom
5.2.5 Spain
5.3 Asia-Pacific
5.3.1 Japan
5.3.2 China
5.3.3 India
6. INDUSTRY TRENDS
6.1 Fast Emerging Niche: Devices to Capture Circulating Tumor Cells
6.2 On the Horizon: Non-Invasive Genetic Tests for Cancer
6.3 Non-Invasive Prenatal Diagnostics Market Witnesses Boom
6.4 Companion Diagnostics Partnerships Gear Up
6.5 Predictive Cancer Diagnostic Test Market Rockets Northwards
6.6 POCT: Expanding Avenues into Multiple Disease Diagnosis
7. COMPETITIVE LANDSCAPE
7.1 Market Share of Top Players
7.2 Key Players
7.2.1 Abbott Laboratories
7.2.2 Alere, Inc.
7.2.3 Becton Dickinson
7.2.4 Bayer HealthCare
7.2.5 Beckman Coulter
7.2.6 Biomerieux
7.2.7 Johnson and Johnson
7.2.8 Life Technologies Corporation
7.2.9 Medtronic, Inc.
7.2.10 Qiagen NV
7.2.11 Roche Holding Ltd
7.2.12 Sysmex Corporation
7.2.13 Siemens HealthCare
7.2.14 Thermo Fisher Scientific
LIST OF FIGURES:
Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 4-2: Global - Point-of-Care Testing Market by Region (%), 2013
Figure 4-3: Global - Point-of-Care Testing Market by Players (%), 2013
Figure 4-4: Global - Point-of-Care Testing Market (Billion US$), 2013-2018
Figure 4-5: Global - Immunochemistry Testing Market by Region (%), 2013
Figure 4-6: Global - Immunochemistry Testing Market by Players (%), 2013
Figure 4-7: Global - Immunochemistry Testing Market (Billion US$), 2013-2018
Figure 4-8: Global - Clinical Chemistry Testing Market by Region (%), 2013
Figure 4-9: Global - Clinical Chemistry Testing Market by Players (%), 2013
Figure 4-10: Global - Clinical Chemistry Testing Market (Billion US$), 2013-2018
Figure 4-11: Global - Molecular Diagnostics Market by Region (%), 2013
Figure 4-12: Global - Molecular Diagnostics Market by Players (%), 2013
Figure 4-13: Global - Molecular Diagnostics Market (Billion US$), 2013-2018
Figure 4-14: Global - Hematology Testing Market by Region (%), 2013
Figure 4-15: Global - Hematology Testing Market by Players (%), 2013
Figure 4-16: Global - Hematology Testing Market (Billion US$), 2013-2018
Figure 4-17: Global - Microbiology Testing Market by Region (%), 2013
Figure 4-18: Global - Microbiology Testing Market by Players (%), 2013
Figure 4-19: Global - Microbiology Testing Market (Billion US$), 2013-2018
Figure 4-20: Global - Hemostasis Testing Market by Region (%), 2013
Figure 4-21: Global - Hemostasis Testing Market by Players (%), 2013
Figure 4-22: Global - Hemostasis Testing Market (Billion US$), 2013-2018
Figure 4-23: Global - Immunohematology Testing Market by Region (%), 2013
Figure 4-24: Global - Immunohematology Testing Market (Billion US$), 2013-2018
Figure 5-1: Global - In Vitro Diagnostic Market by Region (%), 2013
Figure 5-2: Global - In Vitro Diagnostic Market by Region (%), 2018
Figure 5-3: US - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-4: US - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-5: US - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-6: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-7: Canada - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-8: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-9: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-10: Brazil - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-11: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-12: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-13: Mexico - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-14: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-15: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-16: Europe - In Vitro Diagnostic Market by Country (%), 2013
Figure 5-17: Europe - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-18: Europe - In Vitro Diagnostic Market by Country (%), 2018
Figure 5-19: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-20: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-21: Germany - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-22: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-23: France - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-24: France - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-25: France - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-26: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-27: Italy - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-28: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-29: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-30: UK - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-31: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-32: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-33: Spain - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-34: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-35: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-36: Japan - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-37: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-38: China - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-39: China - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-40: China - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-41: India - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-42: India - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-43: India - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 7-1: Global - In Vitro Diagnostic Market by Players (%), 2013
Figure 7-2: Abbott Laboratories - Break up of Revenue by Business Segment (%), 2013
Figure 7-3: Abbott Laboratories - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-4: Alere Inc. - Break up of Revenue by Business Segment (%), 2012
Figure 7-5: Alere Inc. - Diagnostic Division Revenue by Segment (%), 2012
Figure 7-6: Becton Dickinson - Break up of Revenue by Business Segment (%), 2013
Figure 7-7: Becton Dickinson - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-8: Bayer HealthCare - Break up of Revenue by Business Segment (%), 2013
Figure 7-9: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2013
Figure 7-10: Beckman Coulter - Break up of Revenue by Business Segment (%), 2010
Figure 7-11: Beckman Coulter - Diagnostic Division Revenue by Segment (%), 2010
Figure 7-12: Biomerieux - Break up of Revenue by Business Segment (%), 2013
Figure 7-13: Biomerieux - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-14: Johnson & Johnson - Break up of Revenue by Business Segment (%), 2013
Figure 7-15: Life Technologies Corporation - Break up of Revenue by Business Segment (%), 2012
Figure 7-16: Medtronic Inc. - Break up of Revenue by Business Segment (%), 2013
Figure 7-17: Qiagen NV - Break up of Revenue by Business Segment (%), 2013
Figure 7-18: Roche Holdings Ltd - Break up of Revenue by Business Segment (%), 2013
Figure 7-19: Roche Holdings Ltd - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-20: Sysmex Corp. - Break up of Revenue by Business Segment (%), 2013
Figure 7-21: Sysmex Corp. - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-22: Siemens HealthCare - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-23: Thermo Fisher Scientific - Break up of Revenue by Business Segment (%), 2012
Figure 3-1: Global - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 4-2: Global - Point-of-Care Testing Market by Region (%), 2013
Figure 4-3: Global - Point-of-Care Testing Market by Players (%), 2013
Figure 4-4: Global - Point-of-Care Testing Market (Billion US$), 2013-2018
Figure 4-5: Global - Immunochemistry Testing Market by Region (%), 2013
Figure 4-6: Global - Immunochemistry Testing Market by Players (%), 2013
Figure 4-7: Global - Immunochemistry Testing Market (Billion US$), 2013-2018
Figure 4-8: Global - Clinical Chemistry Testing Market by Region (%), 2013
Figure 4-9: Global - Clinical Chemistry Testing Market by Players (%), 2013
Figure 4-10: Global - Clinical Chemistry Testing Market (Billion US$), 2013-2018
Figure 4-11: Global - Molecular Diagnostics Market by Region (%), 2013
Figure 4-12: Global - Molecular Diagnostics Market by Players (%), 2013
Figure 4-13: Global - Molecular Diagnostics Market (Billion US$), 2013-2018
Figure 4-14: Global - Hematology Testing Market by Region (%), 2013
Figure 4-15: Global - Hematology Testing Market by Players (%), 2013
Figure 4-16: Global - Hematology Testing Market (Billion US$), 2013-2018
Figure 4-17: Global - Microbiology Testing Market by Region (%), 2013
Figure 4-18: Global - Microbiology Testing Market by Players (%), 2013
Figure 4-19: Global - Microbiology Testing Market (Billion US$), 2013-2018
Figure 4-20: Global - Hemostasis Testing Market by Region (%), 2013
Figure 4-21: Global - Hemostasis Testing Market by Players (%), 2013
Figure 4-22: Global - Hemostasis Testing Market (Billion US$), 2013-2018
Figure 4-23: Global - Immunohematology Testing Market by Region (%), 2013
Figure 4-24: Global - Immunohematology Testing Market (Billion US$), 2013-2018
Figure 5-1: Global - In Vitro Diagnostic Market by Region (%), 2013
Figure 5-2: Global - In Vitro Diagnostic Market by Region (%), 2018
Figure 5-3: US - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-4: US - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-5: US - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-6: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-7: Canada - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-8: Canada - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-9: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-10: Brazil - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-11: Brazil - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-12: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-13: Mexico - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-14: Mexico - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-15: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-16: Europe - In Vitro Diagnostic Market by Country (%), 2013
Figure 5-17: Europe - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-18: Europe - In Vitro Diagnostic Market by Country (%), 2018
Figure 5-19: Europe - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-20: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-21: Germany - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-22: Germany - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-23: France - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-24: France - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-25: France - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-26: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-27: Italy - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-28: Italy - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-29: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-30: UK - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-31: UK - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-32: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-33: Spain - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-34: Spain - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-35: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-36: Japan - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-37: Japan - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-38: China - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-39: China - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-40: China - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 5-41: India - In Vitro Diagnostic Market by Clinical Segment (%), 2013
Figure 5-42: India - In Vitro Diagnostic Market (Billion US$), 2013-2018
Figure 5-43: India - In Vitro Diagnostic Market by Clinical Segment (%), 2018
Figure 7-1: Global - In Vitro Diagnostic Market by Players (%), 2013
Figure 7-2: Abbott Laboratories - Break up of Revenue by Business Segment (%), 2013
Figure 7-3: Abbott Laboratories - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-4: Alere Inc. - Break up of Revenue by Business Segment (%), 2012
Figure 7-5: Alere Inc. - Diagnostic Division Revenue by Segment (%), 2012
Figure 7-6: Becton Dickinson - Break up of Revenue by Business Segment (%), 2013
Figure 7-7: Becton Dickinson - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-8: Bayer HealthCare - Break up of Revenue by Business Segment (%), 2013
Figure 7-9: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2013
Figure 7-10: Beckman Coulter - Break up of Revenue by Business Segment (%), 2010
Figure 7-11: Beckman Coulter - Diagnostic Division Revenue by Segment (%), 2010
Figure 7-12: Biomerieux - Break up of Revenue by Business Segment (%), 2013
Figure 7-13: Biomerieux - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-14: Johnson & Johnson - Break up of Revenue by Business Segment (%), 2013
Figure 7-15: Life Technologies Corporation - Break up of Revenue by Business Segment (%), 2012
Figure 7-16: Medtronic Inc. - Break up of Revenue by Business Segment (%), 2013
Figure 7-17: Qiagen NV - Break up of Revenue by Business Segment (%), 2013
Figure 7-18: Roche Holdings Ltd - Break up of Revenue by Business Segment (%), 2013
Figure 7-19: Roche Holdings Ltd - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-20: Sysmex Corp. - Break up of Revenue by Business Segment (%), 2013
Figure 7-21: Sysmex Corp. - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-22: Siemens HealthCare - Diagnostic Division Revenue by Segment (%), 2013
Figure 7-23: Thermo Fisher Scientific - Break up of Revenue by Business Segment (%), 2012
LIST OF TABLES:
Table 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
Table 4-2: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2018
Table 5-1: Europe - Percentage of People Aged 65+ Years in Top-5 IVD Markets (2013 & 2018)
Table 7-1: Abbott Laboratories - Key Financials (Million US$), 2011-2013
Table 7-2: Abbott Laboratories - Strengths and Weaknesses
Table 7-3: Alere Inc. - Key Financials (Million US$), 2010-2012
Table 7-4: Alere Inc. - Strengths and Weaknesses
Table 7-5: Becton Dickinson - Key Financials (Million US$), 2011-2013
Table 7-6: Becton Dickinson - Strengths and Weaknesses
Table 7-7: Bayer HealthCare - Key Financials (Million €), 2011-2013
Table 7-8: Bayer HealthCare - Strengths and Weaknesses
Table 7-9: Beckman Coulter - Strengths and Weaknesses
Table 7-10: Biomerieux - Key Financials (Million €), 2011-2013
Table 7-11: Biomerieux - Strengths and Weaknesses
Table 7-12: Johnson & Johnson - Key Financials (Million US$), 2011-2013
Table 7-13: Johnson & Johnson - Strengths and Weaknesses
Table 7-14: Life Technologies Corporation - Key Financials (Million US$), 2010-2012
Table 7-15; Life Technologies Corporation - Strengths and Weaknesses
Table 7-16: Medtronic Inc. - Key Financials (Million US$), 2011-2013
Table 7-17; Medtronic Inc. - Strengths and Weaknesses
Table 7-18: Qiagen NV - Key Financials (Million US$), 2011-2013
Table 7-19: Qiagen NV - Strengths and Weaknesses
Table 7-20: Roche Holding Ltd - Key Financials (Million CHF), 2011-2013
Table 7-21; Roche Holding Ltd - Strengths and Weaknesses
Table 7-22: Sysmex Corp. - Key Financials (Million Yen), 2011-2013
Table 7-23: Sysmex Corp. - Strengths and Weaknesses
Table 7-24: Siemens AG - Key Financials (Million €), 2011-2013
Table 7-25: Siemens - Strength and Weaknesses
Table 7-26: Thermo Fisher Scientific - Key Financials (Million US$) 2010-2012
Table 7-27: Thermo Fisher Scientific Inc. - Strengths and Weaknesses
Table 4-1: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2013
Table 4-2: Global - In Vitro Diagnostic Market by Clinical Segment (Billion US$), 2018
Table 5-1: Europe - Percentage of People Aged 65+ Years in Top-5 IVD Markets (2013 & 2018)
Table 7-1: Abbott Laboratories - Key Financials (Million US$), 2011-2013
Table 7-2: Abbott Laboratories - Strengths and Weaknesses
Table 7-3: Alere Inc. - Key Financials (Million US$), 2010-2012
Table 7-4: Alere Inc. - Strengths and Weaknesses
Table 7-5: Becton Dickinson - Key Financials (Million US$), 2011-2013
Table 7-6: Becton Dickinson - Strengths and Weaknesses
Table 7-7: Bayer HealthCare - Key Financials (Million €), 2011-2013
Table 7-8: Bayer HealthCare - Strengths and Weaknesses
Table 7-9: Beckman Coulter - Strengths and Weaknesses
Table 7-10: Biomerieux - Key Financials (Million €), 2011-2013
Table 7-11: Biomerieux - Strengths and Weaknesses
Table 7-12: Johnson & Johnson - Key Financials (Million US$), 2011-2013
Table 7-13: Johnson & Johnson - Strengths and Weaknesses
Table 7-14: Life Technologies Corporation - Key Financials (Million US$), 2010-2012
Table 7-15; Life Technologies Corporation - Strengths and Weaknesses
Table 7-16: Medtronic Inc. - Key Financials (Million US$), 2011-2013
Table 7-17; Medtronic Inc. - Strengths and Weaknesses
Table 7-18: Qiagen NV - Key Financials (Million US$), 2011-2013
Table 7-19: Qiagen NV - Strengths and Weaknesses
Table 7-20: Roche Holding Ltd - Key Financials (Million CHF), 2011-2013
Table 7-21; Roche Holding Ltd - Strengths and Weaknesses
Table 7-22: Sysmex Corp. - Key Financials (Million Yen), 2011-2013
Table 7-23: Sysmex Corp. - Strengths and Weaknesses
Table 7-24: Siemens AG - Key Financials (Million €), 2011-2013
Table 7-25: Siemens - Strength and Weaknesses
Table 7-26: Thermo Fisher Scientific - Key Financials (Million US$) 2010-2012
Table 7-27: Thermo Fisher Scientific Inc. - Strengths and Weaknesses
